Cholestech to Present at the 8th Annual B. Riley Las Vegas Investor Conference
08 März 2007 - 12:35AM
PR Newswire (US)
HAYWARD, Calif., March 7 /PRNewswire-FirstCall/ -- Cholestech
Corporation (NASDAQ:CTEC), a leading manufacturer of point of care
testing devices, today announced that Jack Glenn, CFO and Ken
Miller, Vice President of Sales and Marketing will present at the
B. Riley 8th Annual Las Vegas Investor Conference on Wednesday,
March 14, 2007, at 12:35 p.m. Pacific Time in Las Vegas, Nevada.
The presentation will include an overview of the company, current
products, product pipeline and recent financial performance; and
will be webcast and accessible on Cholestech's website at
http://www.cholestech.com/. About Cholestech Cholestech is
committed to enabling people to lead longer, healthier and more
active lives. Cholestech provides easy to use, accessible
diagnostic tools and information to health care practitioners in
over 35 countries around the world. Cholestech offers efficient and
economic diagnostic testing for cholesterol and related lipids,
blood glucose and glycemic control, and liver enzymes at the point
of care. Health care providers can use the CLIA-waived Cholestech
LDX(R) and GDX(TM)* Systems and the hs-CRP test, which is cleared
by the FDA for use in moderate complexity labs, to initiate and
monitor the progress of patient therapy. By providing effective
disease management solutions, Cholestech's goal is to be a leading
provider of diagnostic tools and information for immediate risk
assessment and therapeutic monitoring of heart disease,
inflammatory disorders and diabetes. *The GDX system is 510(k)
cleared for prescription home use and, accordingly, is CLIA waived.
Cholestech LDX is a registered trademark and Cholestech GDX is a
trademark of Cholestech Corporation. All other trademarks mentioned
in this document are the property of their respective owners. For
more information about Cholestech and its products visit us on the
web at http://www.cholestech.com/. DATASOURCE: Cholestech
Corporation CONTACT: Jack Glenn, Chief Financial Officer of
Cholestech Corporation, +1-510-781-5065, or ; or investors, Brendan
Lahiff of Financial Dynamics, +1-415-439-4504, or , for Cholestech
Corporation Web site: http://www.cholestech.com/
Copyright
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Global X CleanTech ETF (NASDAQ:CTEC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Global X CleanTech ETF (NASDAQ): 0 Nachrichtenartikel
Weitere Cholestech (MM) News-Artikel